Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMP with 5-FU for IGH Repigmentation
NCT02904564Phase 4Unknown
- Sponsor
- Clinica Dermatologica Arbache
- Start
- Aug 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluorouracil in Idiopathic Guttate Hypomelanosis (IGH), sponsored by Clinica Dermatologica Arbache. Status: unknown.
02
Drugs
fluorouracil
03
Conditions
Idiopathic Guttate Hypomelanosis (IGH)
Beyond the preview
Go deeper on NCT02904564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02904564.